ARTANBIO Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $200K

  • Investors
  • 1

ARTANBIO General Information

Description

Developer of genetic therapy technology designed to address genetic and age-related diseases caused by nonsense mutations. The company's platform utilizes engineered suppressor transfer RNA systems that specifically recognize faulty codons responsible for premature protein translation termination, restore normal protein synthesis, support the production of complete functional proteins, and target mutation-driven disease mechanisms, enabling patients with rare genetic disorders and age-related conditions to regain functional protein expression.

Contact Information

Website
www.artan.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Saint Petersburg
  • Russia
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • Saint Petersburg
  • Russia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ARTANBIO Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 04-Jun-2026 $200K Completed Startup
To view ARTANBIO’s complete valuation and funding history, request access »

ARTANBIO Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

ARTANBIO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198635-A1 Multi-copy number suppressor trna construct Pending 18-Mar-2025
WO-2026161797-A1 Suppressor trna construct with spacer sequences for treating stop-codon-associated diseases Pending 24-Jan-2025

ARTANBIO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ARTANBIO Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
VitaDAO Venture Capital Minority
To view ARTANBIO’s complete investors history, request access »

Ready to get started?

Request a free trial

ARTANBIO FAQs

  • When was ARTANBIO founded?

    ARTANBIO was founded in 2023.

  • Where is ARTANBIO headquartered?

    ARTANBIO is headquartered in Saint Petersburg, Russia.

  • What is the size of ARTANBIO?

    ARTANBIO has 2 total employees.

  • What industry is ARTANBIO in?

    ARTANBIO’s primary industry is Biotechnology.

  • Is ARTANBIO a private or public company?

    ARTANBIO is a Private company.

  • What is ARTANBIO’s current revenue?

    The current revenue for ARTANBIO is .

  • How much funding has ARTANBIO raised over time?

    ARTANBIO has raised $200K.

  • Who are ARTANBIO’s investors?

    VitaDAO has invested in ARTANBIO.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process